sb 206553 has been researched along with Anochlesia in 1 studies
SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kołaczkowski, M | 1 |
| Marcinkowska, M | 1 |
| Bucki, A | 1 |
| Pawłowski, M | 1 |
| Mitka, K | 1 |
| Jaśkowska, J | 1 |
| Kowalski, P | 1 |
| Kazek, G | 1 |
| Siwek, A | 1 |
| Wasik, A | 1 |
| Wesołowska, A | 1 |
| Mierzejewski, P | 1 |
| Bienkowski, P | 1 |
1 other study available for sb 206553 and Anochlesia
| Article | Year |
|---|---|
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; C | 2014 |